NL7807507A
(nl)
|
1977-07-25 |
1979-01-29 |
Hoffmann La Roche |
Tricyclische verbindingen.
|
US4146718A
(en)
*
|
1978-04-10 |
1979-03-27 |
Bristol-Myers Company |
Alkyl 5,6-dichloro-3,4-dihydro-2(1h)-iminoquinazoline-3-acetate hydrohalides
|
CA1131631A
(en)
*
|
1979-06-20 |
1982-09-14 |
Madhukar S. Chodnekar |
Quinazoline derivatives and pharmaceutical preparations
|
EP0029559A3
(en)
*
|
1979-11-24 |
1981-09-30 |
Sandoz Ag |
5,10-dihydroimidazo(2,1-b)quinazolines, their production and pharmaceutical compositions containing them
|
US4444768A
(en)
*
|
1980-03-04 |
1984-04-24 |
Ciba-Geigy Corporation |
Pyrimido[1,6-a]indoles, pharmaceutical preparations containing them, and methods of treating pain and inflammation with them
|
ZW16481A1
(en)
*
|
1980-08-15 |
1982-03-10 |
Hoffmann La Roche |
Novel imidazoquinazoline derivatives
|
EP0054180A3
(de)
*
|
1980-12-16 |
1982-12-01 |
F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft |
Verfahren zur Herstellung eines Imidazochinazolinonderivates
|
JPS57178234U
(it)
*
|
1981-05-06 |
1982-11-11 |
|
|
US4455311A
(en)
*
|
1981-08-28 |
1984-06-19 |
Hoffmann-La Roche Inc. |
Imidazoquinazoline derivatives which inhibit the aggregation of blood platelets, inhibit gastric secretion or have activity on the circulatory system
|
US4663320A
(en)
*
|
1983-02-16 |
1987-05-05 |
Syntex (U.S.A.) Inc. |
(2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylamides, compositions and the use thereof
|
US4490371A
(en)
*
|
1983-02-16 |
1984-12-25 |
Syntex (U.S.A.) Inc. |
N,N-Disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl)oxyalkylamides
|
US4551459A
(en)
*
|
1983-02-16 |
1985-11-05 |
Syntex (U.S.A.) Inc. |
Method of treating heart failure using (2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-b]quinazolinyl)oxyalkylamides
|
JPS604186A
(ja)
*
|
1983-06-21 |
1985-01-10 |
Dai Ichi Seiyaku Co Ltd |
イミダゾキナゾリン化合物
|
JPS6028979A
(ja)
*
|
1983-07-14 |
1985-02-14 |
Dai Ichi Seiyaku Co Ltd |
イミダゾキナゾリン類化合物
|
HU193409B
(en)
*
|
1984-02-15 |
1987-10-28 |
Syntex Inc |
Process for producing 2-square bracket -n-cyclohexyl-4-bracket-oxo-1,2,3,5-tetrahydro-imidazo-square bracket-2,1-b-square bracket closed-quinazolin-7-yl-bracket closed-oxy-alkqne-carboxamidyl-square bracket closed-alkan-acides
|
GB8514207D0
(en)
*
|
1985-06-05 |
1985-07-10 |
Pfizer Ltd |
Cardiac stimulants
|
US4783467A
(en)
*
|
1985-06-05 |
1988-11-08 |
Pfizer Inc. |
Tetrahydroimidazoquinazolinone inotropic agents
|
US4837239A
(en)
*
|
1985-08-23 |
1989-06-06 |
Syntex (U.S.A.) Inc. |
Cardiotonic phosphodiesterase inhibitors complexed with water soluble vitamins
|
US4670434A
(en)
*
|
1985-11-14 |
1987-06-02 |
Syntex (U.S.A.) Inc. |
(2-oxo-3-methylene-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolinyl)oxyalkylamides useful as cyclic AMP phosphodiesterase inhibitors
|
US4775674A
(en)
*
|
1986-05-23 |
1988-10-04 |
Bristol-Myers Company |
Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors
|
US4701459A
(en)
*
|
1986-07-08 |
1987-10-20 |
Bristol-Myers Company |
7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation
|
US5043327A
(en)
*
|
1989-07-18 |
1991-08-27 |
Janssen Pharmaceutica N.V. |
Positive inotropic and lusitropic 3,5-dihydroimidazo[2,1-b]quinazolin-2(1H)-one derivatives, compositions and use
|
US4943573A
(en)
*
|
1989-11-01 |
1990-07-24 |
Bristol-Myers Squibb Company |
Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
|
CA2113115A1
(en)
*
|
1991-07-29 |
1993-02-18 |
Vlad E. Gregor |
Quinazoline derivatives as acetylcholinesterase inhibitors
|
US5348960A
(en)
*
|
1992-04-03 |
1994-09-20 |
Bristol-Myers Squibb Company |
Imidazo[4,5-b]quinolinyl oxy alkyl tetrazolyl piperidine derivatives
|
US5208237A
(en)
*
|
1992-04-03 |
1993-05-04 |
Bristol-Meyers Squibb Company |
7-oxypropylsulfonamido-imidazo[4,5-b]quinolin-2-ones
|
US5196428A
(en)
*
|
1992-04-03 |
1993-03-23 |
Bristol-Myers Squibb Company |
Imidazo[4,5-b]qinolinyl oxy alkyl ureas
|
US5158958A
(en)
*
|
1992-04-03 |
1992-10-27 |
Bristol-Myers Squibb Company |
Imidazo[4,5-b]quinolinyl oxy alkyl sulfonyl piperidine derivatives
|
JPH06167328A
(ja)
*
|
1992-05-26 |
1994-06-14 |
Mayekawa Mfg Co Ltd |
氷厚測定装置
|
EP1216037A2
(en)
*
|
1999-09-21 |
2002-06-26 |
Emory University |
Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents
|
US6388073B1
(en)
*
|
2000-07-26 |
2002-05-14 |
Shire Us Inc. |
Method for the manufacture of anagrelide
|
CA2513708C
(en)
*
|
2003-01-23 |
2011-01-04 |
Shire Holdings Ag |
Formulation and methods for the treatment of thrombocythemia
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
US20060030574A1
(en)
*
|
2004-08-04 |
2006-02-09 |
Shire Holdings Ag |
Quinazoline derivatives useful for the treatment of peripheral arterial disease and as phosphodiesterase inhibitors
|
US7700608B2
(en)
|
2004-08-04 |
2010-04-20 |
Shire Holdings Ag |
Quinazoline derivatives and their use in the treatment of thrombocythemia
|
US8426429B2
(en)
|
2004-08-06 |
2013-04-23 |
Jansssen Pharmaceutica N.V. |
2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
|
US8436006B2
(en)
|
2004-08-06 |
2013-05-07 |
Jansssen Pharmaceutica N.V. |
2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
|
US8383637B2
(en)
|
2004-08-06 |
2013-02-26 |
Jansssen Pharmaceutica N.V. |
2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
|
GB0623750D0
(en)
*
|
2006-11-28 |
2007-01-10 |
Shire Llc |
Substituted quinazolines
|
US7910597B2
(en)
*
|
2006-11-28 |
2011-03-22 |
Shire Llc |
Substituted quinazolines
|
US8304420B2
(en)
|
2006-11-28 |
2012-11-06 |
Shire Llc |
Substituted quinazolines for reducing platelet count
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
MX354786B
(es)
|
2007-06-04 |
2018-03-21 |
Synergy Pharmaceuticals Inc |
Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
|
GB0808952D0
(en)
*
|
2008-05-16 |
2008-06-25 |
Shire Llc |
Substituted quinazolines
|
GB0808968D0
(en)
*
|
2008-05-16 |
2008-06-25 |
Shire Llc |
Substitute quinazolines
|
GB0808944D0
(en)
*
|
2008-05-16 |
2008-06-25 |
Shire Llc |
Substituted quinazolines
|
GB0808953D0
(en)
*
|
2008-05-16 |
2008-06-25 |
Shire Llc |
substituted quinazolines
|
GB0808950D0
(en)
*
|
2008-05-16 |
2008-06-25 |
Shire Llc |
Substituted quinazolines
|
GB0808967D0
(en)
*
|
2008-05-16 |
2008-06-25 |
Shire Llc |
Substitute quinazolines
|
GB0808947D0
(en)
*
|
2008-05-16 |
2008-06-25 |
Shire Llc |
Substituted quinazolines
|
GB0808948D0
(en)
*
|
2008-05-16 |
2008-06-25 |
Shire Llc |
Substituted quinazolines
|
GB0808951D0
(en)
*
|
2008-05-16 |
2008-06-25 |
Shire Llc |
Substituted quinazolines
|
GB0810005D0
(en)
*
|
2008-06-02 |
2008-07-09 |
Shire Llc |
Substituted quinazolines
|
CA2726917C
(en)
|
2008-06-04 |
2018-06-26 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
WO2010009319A2
(en)
|
2008-07-16 |
2010-01-21 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
GB0822970D0
(en)
|
2008-12-17 |
2009-01-21 |
Shire Llc |
Process for the preparation of anagrelide and analogues
|
GB201004491D0
(en)
|
2010-03-18 |
2010-05-05 |
Shire Llc |
Quinazoline analogues
|
GB201004495D0
(en)
|
2010-03-18 |
2010-05-05 |
Shire Llc |
Subtituted quinazolines
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
US9580471B2
(en)
|
2011-03-01 |
2017-02-28 |
Synergy Pharmaceuticals, Inc. |
Process of preparing guanylate cyclase C agonists
|
US9545446B2
(en)
|
2013-02-25 |
2017-01-17 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase and their uses
|
EP2970384A1
(en)
|
2013-03-15 |
2016-01-20 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
WO2014151200A2
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|
JP6606491B2
(ja)
|
2013-06-05 |
2019-11-13 |
シナジー ファーマシューティカルズ インコーポレイテッド |
グアニル酸シクラーゼcの超高純度アゴニスト、その作成および使用方法
|
JP6694385B2
(ja)
|
2013-08-09 |
2020-05-13 |
アーデリクス,インコーポレーテッド |
リン酸塩輸送阻害のための化合物及び方法
|
JP5935843B2
(ja)
*
|
2014-08-08 |
2016-06-15 |
Jfeスチール株式会社 |
スポット溶接性に優れた冷延鋼板およびその製造方法
|
WO2020237096A1
(en)
|
2019-05-21 |
2020-11-26 |
Ardelyx, Inc. |
Combination for lowering serum phosphate in a patient
|
EP4201403A1
(en)
|
2021-12-21 |
2023-06-28 |
Som Innovation Biotech, S.L. |
Compounds tirapazamine and quazinone for use in the treatment of gm2 gangliosidoses
|